All relevant data are within the manuscript and its Supporting Information files.

Introduction {#sec005}
============

Life expectancy has increased substantially worldwide over the last decades \[[@pone.0226613.ref001]\], resulting in an increased prevalence of people living with chronic diseases and disabilities \[[@pone.0226613.ref002]\]. Individuals' self-perceived well-being, function and health status have therefore become important indicators of health policies and health interventions \[[@pone.0226613.ref003]\]. Health-related quality of life (HRQoL) is a measure that includes several concepts, and covers physical-, mental- and social-health dimensions \[[@pone.0226613.ref003]\]. Furthermore, as populations' age and chronic conditions increase, there is a need to promote behaviors that might prevent disability and hospitalization. Physical activity (PA) has well-documented beneficial effects on prevention and treatment of non-communicable diseases (NCDs) and other chronic conditions \[[@pone.0226613.ref004]--[@pone.0226613.ref006]\] as well as on promotion of HRQoL \[[@pone.0226613.ref007]--[@pone.0226613.ref009]\]. Nevertheless, the existing knowledge about the relationship between PA and HRQoL is primarily based on self-reported measurements of PA \[[@pone.0226613.ref007], [@pone.0226613.ref009]\], which are known to have low correlation to direct measurements of PA, and to be influenced by several biases, such as recall and social desirability biases \[[@pone.0226613.ref010]\]. Duration and intensity of PA, in particular, are difficult to recall precisely \[[@pone.0226613.ref010]--[@pone.0226613.ref012]\], which in turn, hampers the possibility of drawing conclusions about the dose-response relationship between PA and HRQoL.

The current global recommendations for health-enhancing PA for adults and the elderly include PA of minimum moderate intensity (MPA), which equals 3--6 metabolic equivalents (METs), for a total of 150 min per week, or at least 75 min of vigorous intensity PA (VPA) (≥ 6 METs), or any equivalent combination of those, in bouts of at least 10 min duration \[[@pone.0226613.ref013]\]. Although moderate to vigorous PA (MVPA) is recognized as the most important intensity range to improve physiological health indicators \[[@pone.0226613.ref006]\], knowledge of relationships between specific PA intensities and HRQoL is sparse \[[@pone.0226613.ref007], [@pone.0226613.ref009], [@pone.0226613.ref014]\]. Most previous studies target MVPA only \[[@pone.0226613.ref007], [@pone.0226613.ref009]\]. This practice ignores the possible associations between HRQoL and time spent sedentary (SED) or in light PA (LPA). These behaviors are of special interest in older adults and populations with chronic conditions, who tend to be less physically active than the general population and spend most of their active time in LPA \[[@pone.0226613.ref015]--[@pone.0226613.ref017]\]. Previous studies investigating associations between HRQoL and SED or LPA among adults and the elderly have reported conflicting results \[[@pone.0226613.ref017]--[@pone.0226613.ref021]\].

Despite the well-documented health-enhancing effects of PA, there are still many adults and elderly worldwide who are physically inactive (i.e., do not meet PA recommendations). Their numbers represent about 30--90% of adults, depending on assessment methods and study-populations \[[@pone.0226613.ref022]--[@pone.0226613.ref024]\]. In Norway, only about one-third of the adults meet the PA recommendations when measured objectively \[[@pone.0226613.ref024]\]. Therefore, broad multi-sector initiatives are needed to promote PA among physically inactive individuals \[[@pone.0226613.ref025]\]. Thus, as part of the Norwegian national high-risk strategy to achieve the World Health Organization's (WHO's) goals of a 25% reduction of premature deaths caused by NCDs, and a 10% reduction in the number of people being physically inactive \[[@pone.0226613.ref025]\], Healthy Life Centers (HLCs) have been established as a primary health service \[[@pone.0226613.ref026]\]. HLCs provide help to promote behavior change with regard to PA, diet and smoking. The services target individuals with chronic conditions or at high risk of getting diseases, and who need support to change their behavior (hereafter termed high-risk individuals) \[[@pone.0226613.ref027]\]. Although 60% of municipalities in Norway have established HLCs \[[@pone.0226613.ref028]\], knowledge about whom these centers reach is limited. Previous studies of HLCs included small samples and used assessment methods that hamper comparison with the general population's PA level and HRQoL \[[@pone.0226613.ref029]--[@pone.0226613.ref031]\]. Large-sampled studies that use objective instruments to assess PA and SED and multi-dimensional instruments to assess HRQoL are lacking.

Therefore, the aims of this study were: a) to explore levels of objectively measured PA and self-reported dimensions of HRQoL among HLC participants and compare the participants' HRQoL to Norwegian normative data, and b) to study whether time spent in MVPA, LPA and SED was associated with specific dimensions of HRQoL.

Methods {#sec006}
=======

Setting and sample {#sec007}
------------------

In the current paper, we present baseline data from a prospective observational study carried out at 32 HLCs in four regions throughout Norway, as shown in [Fig 1](#pone.0226613.g001){ref-type="fig"}. The HLCs varied in size, years since establishment and resources available. Individuals 18 years of age or older enrolled at one of the included HLCs were invited to participate in the study. They were self-referred, or referred by general practitioners, other health services, or the Norwegian Labor and Welfare Administration, for guidance to improve PA, diet and/or smoking behaviors. The only exclusion criterion was previous enrollment in a HLC intervention during the last 6 months. Data collection was performed in the period between August 2016 and February 2018. Study design and inclusion procedures are explained in more detail elsewhere \[[@pone.0226613.ref032]\]. Among those initially eligible to participate, about 33% declined to take part, 10% were not invited because the professional judgement of HLC staff was that they would be unable to complete questionnaires and physical tests (e.g. due to serious cognitive, physical or mental impairments), and 1% had begun their intervention before agreeing to participate in the study and were therefore excluded. A total of 1,022 individuals agreed to participate and provided written informed consent, representing 56% of those eligible to participate. The estimation of individuals taking part in the study was based on reports from 26 of the 32 HLCs. In the current study, we included participants with valid assessments of PA and HRQoL, as described in [Fig 1](#pone.0226613.g001){ref-type="fig"}. The study was approved by the Regional Committee for Medical and Health Research Ethics (ref. 2016/546/REK midt).

![Flow of Healthy Life Centers (HLCs) and study participants.](pone.0226613.g001){#pone.0226613.g001}

Norwegian reference values of HRQoL from the survey by Jacobsen et al. \[[@pone.0226613.ref033]\] (N = 2,118, aged 18--80 years with a mean age 55.7 years, conducted in 2015, were used to compare the study population's HRQoL to the Norwegian norms \[[@pone.0226613.ref033]\].

Variables {#sec008}
---------

### Health-related quality of life {#sec009}

HRQoL was assessed by the generic, multidimensional questionnaire Medical Outcome Study 36-item short form (SF-36) version 1.0. \[[@pone.0226613.ref034], [@pone.0226613.ref035]\]. SF-36 is translated and validated in the Norwegian population, and updated reference values have been recently published \[[@pone.0226613.ref033], [@pone.0226613.ref036]\]. The instrument consists of 36 items that assess the following eight dimensions: physical functioning (10 items), role limitations due to physical problems (role physical) (four items), bodily pain (two items), general health perceptions (general health) (five items), vitality (four items), social functioning (two items), role limitations due to emotional problems (role emotional) (three items), mental health generally (five items) and one item measuring health transition (not used in the current study) \[[@pone.0226613.ref035]\]. Participants who completed 50% or more of each dimension's items were included. Imputation of missing data and transformation of item scores were incorporated according to the standard SF-36 algorithm \[[@pone.0226613.ref035]\]. Missing values were replaced with the person's mean score of completed items within the same dimension. Each dimension gave a raw score by averaging the items of the corresponding dimension, which were linearly transformed to a scale of zero (lowest health state) to 100 (highest health state) \[[@pone.0226613.ref035]\].

### Physical activity level and sedentary time {#sec010}

PA level and SED were assessed by ActiGraph GT3X accelerometer (ActiGraph, LLC, Pensacola, Florida, USA). ActiGraph is the most widely used accelerometer and correlates well with energy expenditure derived from the doubly labeled water technique \[[@pone.0226613.ref037]\]. The accelerometer measures acceleration in three axes providing a value called counts. The number of counts per minute (cpm) over a given period provides information about activity, intensity and duration. Despite its limitations in measuring upper-body movement, cycling, water activities, and incline walking with heavy loads, it is valid and reliable for measuring daily PA and time spent in different intensities and SED \[[@pone.0226613.ref010], [@pone.0226613.ref038]\]. Accelerometers were sent by mail to the participants together with information about how to use it and a reminder poster. The participants were instructed to put on the accelerometer by placing it on the right hip the morning after they received it, and were told to wear it for seven consecutive days during waking hours, except when taking a shower or bath. After 7 days, they were asked to deliver the monitor to HLC staff, who returned it together with questionnaires in a prepaid envelope.

Data processing criteria according to Migueles and colleagues were used \[[@pone.0226613.ref039]\], which are the same used in Norwegian population surveys \[[@pone.0226613.ref024], [@pone.0226613.ref040]\]. Accelerometers were initialized in ActiLife software (v 6.13.3, ActiGraph) with a sample frequency of 30 Hz, sleeping mode enabled, and were programmed to start monitoring 2 days after they were sent out by mail, with no defined stop time. Data was downloaded using the same software, normal filtering option and a 10-second epoch setting. Files were later reintegrated to 60-second epochs to match the Norwegian surveys' data processing \[[@pone.0226613.ref024]\]. Non-wear time was defined as a minimum of 60 consecutive minutes with zero counts with allowance of up to 2 min of non-zero counts. We inspected all files individually to identify and remove noise from mail delivery. Wear criteria for a valid measurement was at least 600 min per day for at least 4 days. Only the vertical axis was used to enable application of the well-established cut points from Troiano et al. \[[@pone.0226613.ref041]\], as also previously used in Norwegian population samples \[[@pone.0226613.ref024]\]: SED (0--99 cpm), LPA (100--2,019 cpm), MPA (2,020--5,998 cpm), VPA (≥ 5,999 cpm), and MVPA (≥ 2,020 cpm) intensities. PA outcomes were intensity-specific PA levels reported as average time spent in MVPA, VPA, MPA, LPA and SED per day (min/day), and time spent in 10-min bouts of MVPA (≥ 2,020 cpm) allowing for 2 min drop time (min/day). Overall PA level was reported as total PA (cpm) and average steps per day. Meeting the current recommendations for PA was defined as having an average daily sum of 10-min MVPA bouts that was ≥ 21.4 min/day (150 min per week) \[[@pone.0226613.ref013], [@pone.0226613.ref024], [@pone.0226613.ref042]\]. Average wear time of the accelerometer per day (wear time (min/day)) was calculated as total wear time on valid days divided by number of valid days.

### Covariates {#sec011}

Based on previous findings of associations with HRQoL \[[@pone.0226613.ref043], [@pone.0226613.ref044]\], and after stepwise analyses, we included the following self-reported covariates: gender; age (continuous); and level of education reported as primary school max 10 years, high school max 13 years, college/university ≤ 3 years, and college/university \> 3 years. Marital status was reported as married/partner/cohabitant, divorced/separated/terminated partnership/cohabitation, widow/widower, and never been married/partner/cohabitant, dichotomized as married/partner or not married/partner. Smoking status was reported as never smoked, stopped smoking, smoking sometimes, and currently smoking daily, dichotomized as smoking or not smoking. Chronic conditions were self-reported through the following pre-defined categories: no disease, overweight/obese, muscle/skeletal, hypertension, mental problems, mental disease, diabetes, cardiovascular disease (CVD), lung/respiratory, cancer (current or former), and others (with space to specify). Number of chronic conditions reported were summed and categorized as none, one, or multimorbidity of two, three, or ≥ four chronic conditions (continuous). Body mass index (BMI) was calculated as kg/m^2^ based on measured height and body mass assessed by HLC staff, and categorized according to WHO's classification (Underweight, BMI \< 20; Normal, BMI 20--24; Overweight, BMI 25--29; Obese, BMI ≥ 30) \[[@pone.0226613.ref045]\]. The continuous variable of BMI was used as covariate in analysis of associations, whereas the categories were used for stratification. Occupational status was registered through interviews by HLC staff, but excluded from analysis due to collinearity with chronic conditions.

Statistical analysis {#sec012}
--------------------

Categorical data are presented as frequencies and continuous variables as means and standard deviations (SDs). Descriptive results of PA level, SED and HRQoL variables are presented as unadjusted means (SD) by gender and age (\< 65 / ≥ 65 years). Sensitivity analyses were performed as independent sample t-tests for continuous variables and Mann Whitney U tests for categorical variables between participants (n = 835) and nonparticipants (n = 162). Differences in HRQoL dimension scores between HLC participants and the general Norwegian population are presented as mean scores (SD) and mean differences, and independent sample t-tests were performed to explore statistical differences between populations. According to previous work, 0.2, 0.5 and 0.8 times the SD is considered as respectively small, moderate and large differences in HRQoL scores. A moderate difference is generally considered as a clinically relevant and meaningful difference \[[@pone.0226613.ref046], [@pone.0226613.ref047]\].

Linear relationships between MVPA, LPA or SED and HRQoL dimensions were investigated using scatter plots and by calculation of the p-value for a linear trend with MVPA, LPA and SED as continuous independent variables ([S1 Table](#pone.0226613.s001){ref-type="supplementary-material"}). Because of several nonlinear relationships, individuals were classified into quartiles of time spent in MVPA, LPA and SED. HRQoL dimension scores are presented as unadjusted means (SD) by the quartiles of MVPA, LPA and SED, and analysis of variance (ANOVA) were performed to test the overall differences in scores between the groups (p-values). The quartiles were as follows for MVPA: low: 0--8 min \[reference\]; mid-low: 8--16.9 min; mid-high:17--31 min; and high: \> 31.5 min. LPA: low: \< 211 min \[reference\]; mid-low: 211--259 min; mid-high: 260--317 min; and high: ≥ 318 min. SED: low: \< 496 min \[reference\]; mid-low: 497--562 min; mid-high: 563--618 min; and high: \> 618 min.

Univariate general linear models (GLMs) were performed to investigate associations between each of the eight dimensions of HRQoL as outcomes and each quartile of MVPA, LPA and SED as exposures (independent variables). MVPA, LPA and SED were included in separate models for each of the eight HRQoL dimensions because of the collinearity among PA- and SED variables. However, we also performed sensitivity analyses including adjustment for SED in models for MVPA and adjustment for MVPA in models for LPA and SED. All models were adjusted for the following covariates: age, gender, educational level, marital status, smoking status, chronic condition, BMI and accelerometer wear time. Interaction analyses were performed by including possible interaction terms into all of the GLMs. Gender, age, BMI and chronic conditions were tested as potential moderators, and all four interaction terms (i.e. gender\*MVPA, age\*MVPA, BMI\*MVPA and chronic conditions\*MVPA etc.) were included simultaneously in each of the models. Because of unconcise interaction effects across the HRQoL dimensions, associations between MVPA, LPA or SED with the eight HRQoL dimensions are reported as main effect estimates (B coefficients) along with 95% confidence intervals (Cis) for the total sample. The B coefficients represent differences in SF-36 score points (0--100 scale) compared to the reference quartile. Based on previous work by Sloan et al., 3%, 8% and 13% of the HRQoL scoring range might be considered as small, moderate and large differences, respectively \[[@pone.0226613.ref046]\]. Hence, B ≥ 8 might be considered as a clinically meaningful difference, which corresponds to 0.5 times the SD \[[@pone.0226613.ref046]\]. Interactions are reported with p-values, and for the significant interactions, stratified analyses are presented.

All tests were two-sided, with probability values of 0.05 indicating statistically significant findings. Statistical analyses were performed using IBM Statistics for Windows, Version 24.0 and 25.0 (SPSS Inc., Chicago, Illinois, USA).

Results {#sec013}
=======

Participant characteristics {#sec014}
---------------------------

In total, 835 participants (73% women) provided valid data on PA and SF-36, mean age 49.6 years, ranging from 18--87 years. Ninety-one percent were of Norwegian origin. Thirty percent reported having one chronic condition, whereas 29%, 22%, and 11% reported multimorbidity of two, three, and four or more conditions, respectively. The participants' mean BMI was 32.4 (7.4) kg/m^2^. Detailed information about participants' characteristics is presented in [Table 1](#pone.0226613.t001){ref-type="table"}. Sensitivity analyses showed that the included individuals were older than the individuals who had been excluded from analysis (mean 50 vs. 42 years, respectively, p \< 0.001). However, the two groups did not differ in terms of gender, level of education or BMI.

10.1371/journal.pone.0226613.t001

###### Participant characteristics.

![](pone.0226613.t001){#pone.0226613.t001g}

  Variables                                                              \% (n)
  ---------------------------------------------------------------------- ------------
  **Educational level n = 832**                                          
  **    Primary school, 0--10 years**                                    17.8 (148)
  **    High school, 11--13 years**                                      49.4 (411)
  **    College/university, ≤ 3 years**                                  19.4 (161)
  **    College/university, \> 3 years**                                 13.5 (112)
  **Occupational status n = 831**                                        
  **    Disability pension (full-time)**                                 31.6 (264)
  **    Working (not sick leave or disability pension)**                 25.9 (216)
  **    Part-time working and sick leave/ disability pension**           15.4 (128)
  **    Retiree**                                                        15.4 (128)
  **    Sick leave (full-time)**                                         8.3 (69)
  **    Student**                                                        1.8 (15)
      **Other[^a^](#t001fn001){ref-type="table-fn"}**                    5.1 (42)
  **Chronic conditions[^b^](#t001fn002){ref-type="table-fn"} n = 828**   
  **    No disease**                                                     10.0 (83)
  **    Overweight/obese**                                               49.0 (406)
  **    Muscle/skeletal**                                                41.4 (343)
  **    Hypertension**                                                   27.4 (227)
  **    Mental problems**                                                15.6 (129)
  **    Mental disease**                                                 11.6 (96)
  **    Diabetes**                                                       11.6 (96)
  **    CVD**                                                            10.0 (83)
  **    Lung/respiratory**                                               10.0 (83)
  **    Cancer, current or former**                                      3.5 (29)
      **Other[^c^](#t001fn003){ref-type="table-fn"}**                    16.4 (136)
  **Weight classification n = 796**                                      
  **    Underweight (BMI \< 20)**                                        0.5 (4)
  **    Normal (BMI 20--24)**                                            13.2 (105)
  **    Overweight (BMI 25--29)**                                        25.0 (199)
  **    Obese (BMI ≥ 30)**                                               61.4 (488)
  **Smoking status n = 825**                                             
  **    Never smoked**                                                   37.2 (307)
  **    Stopped smoking**                                                39.5 (326)
  **    Smoking sometimes**                                              5.0 (41)
  **    Smoking daily**                                                  18.3 (151)
  **Marital status n = 835**                                             
  **    Married/partner**                                                64.1 (535)
  **    Not married/partner**                                            35.9 (300)

^a^Maternity leave, homemakers, i.a.

^b^It was possible to report more than one condition, therefore the total percentage adds up to more than 100%.

^c^Other chronic conditions include fatigue/ME, headache, hypothyroidism, rheumatic diseases, neurologic, psoriasis, syndromes, hypercholesterolemia, allergy, i.a.

CVD = Cardiovascular diseases, BMI = Body mass Index

Physical activity level {#sec015}
-----------------------

The included participants had a median of seven valid days of PA registration. Overall, 19% of the participants achieved the recommended amount of PA (≥ 150 min/week in 10-min bouts of MVPA). The participants' intensity-specific PA levels, average wear time per day and overall PA level are shown in [Table 2](#pone.0226613.t002){ref-type="table"}, by gender and age categories.

10.1371/journal.pone.0226613.t002

###### Physical activity level presented as mean (SD) by gender and age categories.

![](pone.0226613.t002){#pone.0226613.t002g}

                                               Total           Women           Men             Adults          Older adults
  -------------------------------------------- --------------- --------------- --------------- --------------- ---------------
  **MVPA (min/day)**                           22.7 (19.1)     22.3 (18.2)     23.8 (21.3)     24.1 (19.4)     16.4 (16.2)
  **Vigorous (min/day)**                       0.4 (2.0)       0.5 (2.2)       0.4 (1.2)       0.5 (2.2)       0.1 (0.3)
  **Moderate (min/day)**                       22.4 (18.7)     22.0 (17.7)     23.5 (21.0)     23.7 (19.0)     16.4 (16.1)
  **Light (min/day)**                          269 (80)        282 (76)        235 (79)        275 (80)        239 (72)
  **Sedentary (min/day)**                      562 (93)        548 (89)        598 (94)        556 (92)        591 (92)
  **Time in 10-min bouts of MVPA (min/day)**   10.9 (14.9)     10.8 (14.4)     11.2 (16.1)     11.5 (15.3)     8.4 (12.4)
  **Wear time (min/day)**                      853 (81)        852 (80)        857 (83)        855 (82)        846 (76)
  **Total PA (cpm)**                           265 (116)       271 (111)       248 (127)       276 (115)       211 (106)
  **Steps per day**                            5,878 (2,570)   6,009 (2,444)   5,530 (2,851)   6,135 (2,548)   4,680 (2,341)
  **Meeting PA recommendations (%)**           18.6            18.6            18.3            19.6            13.5

PA = physical activity, MVPA = moderate to vigorous intensity PA, cpm = counts per minute.

Adults (18--64 years), Older adults (65--87 years)

\*n = 6 did not report age.

Health-related quality of life {#sec016}
------------------------------

Among the included sample (n = 835) with \> 50% completed items within all SF-36 dimensions, 93.5% competed all items, 5.1% missed one item and 1.3% missed 2--4 items overall. For detailed information on missing item pattern, see [S2 Table](#pone.0226613.s002){ref-type="supplementary-material"}.

The HLC participants' HRQoL scores were 10 to 28 points lower than the general Norwegian population's scores across all dimensions and genders (all p-values \< 0.001, and all differences above the clinically meaningful difference of 8 points). [Table 3](#pone.0226613.t003){ref-type="table"} shows HLC participants' HRQoL scores compared to reference values from the general Norwegian adult population \[[@pone.0226613.ref033]\] along with differences in mean scores between the two groups.

10.1371/journal.pone.0226613.t003

###### HRQoL scores (0--100) (SD) for Healthy Life Centre (HLC) population compared to the normal population (norm) by gender.

![](pone.0226613.t003){#pone.0226613.t003g}

                         Women                                          Men                         
  ---------------------- ------------- ------------- ------------------ ------------- ------------- ------------------
  Physical functioning   74.8 (17.6)   84.9 (21.0)   -10.1 (p\<0.001)   75.8 (19.0)   88.1 (17.0)   -12.3 (p\<0.001)
  Role physical          46.4 (41.9)   72.6 (39.6)   -26.2 (p\<0.001)   50.9 (41.6)   78.9 (35.3)   -28.0 (p\<0.001)
  Bodily pain            52.2 (27.4)   66.9 (26.5)   -14.7 (p\<0.001)   58.1 (29.8)   72.1 (25.4)   -14.0 (p\<0.001)
  General health         52.7 (21.9)   72.6 (22.5)   -19.9 (p\<0.001)   51.0 (21.4)   73.4 (20.8)   -22.4 (p\<0.001)
  Vitality               40.0 (19.9)   57.2 (20.6)   -17.2 (p\<0.001)   45.1 (20.0)   61.9 (18.9)   -16.8 (p\<0.001)
  Social functioning     67.8 (28.3)   85.7 (21.6)   -17.9 (p\<0.001)   72.2 (28.0)   89.0 (19.3)   -16.8 (p\<0.001)
  Role emotional         64.2 (42.8)   87.4 (28.6)   -23.2 (p\<0.001)   64.1 (40.9)   89.5 (26.3)   -25.4 (p\<0.001)
  Mental health          67.4 (19.7)   79.9 (14.8)   -12.5 (p\<0.001)   71.4 (20.5)   81.9 (13.8)   -10.5 (p\<0.001)

Differences in scores between the HLC- and norm populations, with corresponding p-values, are presented for each dimension.

HRQoL scores varied across quartile levels of MVPA, LPA and SED ([Table 4](#pone.0226613.t004){ref-type="table"}). For MVPA, significant differences between quartiles were found for physical functioning, role physical and general health. For LPA, we observed significant differences between quartiles for physical functioning, role physical, general health, vitality, social functioning and role emotional. For SED, significant differences between quartiles were found for physical functioning and mental health.

10.1371/journal.pone.0226613.t004

###### HRQoL dimension scores (0--100, (SD)) by quartile levels of MVPA, LPA and SED.

![](pone.0226613.t004){#pone.0226613.t004g}

              Physical functioning                              Role physical                                     Bodily pain   General health                                    Vitality                                     Social functioning                           Role emotional                                 Mental health
  ----------- ------------------------------------------------- ------------------------------------------------- ------------- ------------------------------------------------- -------------------------------------------- -------------------------------------------- ---------------------------------------------- ----------------------------------------------
  **MVPA**                                                                                                                                                                                                                                                                                                                 
  Low         65.4 (19.9)                                       37.2 (40.2)                                       50.0 (28.6)   49.0 (21.4)                                       41.2 (19.1)                                  69.1 (28.1)                                  63.4 (42.6)                                    71.0 (19.4)
  Mid-low     75.7 (16.8)                                       47.9 (41.0)                                       53.3 (28.1)   50.9 (21.5)                                       40.1 (20.4)                                  68.1 (29.0)                                  65.2 (40.9)                                    66.6 (21.1)
  Mid-high    78.7 (16.8)                                       51.7 (43.3)                                       55.4 (28.6)   53.7 (22.2)                                       42.3 (21.3)                                  70.7 (28.5)                                  66.1 (42.2)                                    67.9 (19.8)
  High        79.9 (14.7)                                       52.9 (41.4)                                       56.3 (27.2)   55.1 (21.5)                                       42.0 (19.3)                                  68.1 (27.7)                                  62.0 (43.5)                                    68.6 (19.4)
  p-value     \< 0.001[\*\*](#t004fn002){ref-type="table-fn"}   \< 0.001[\*\*](#t004fn002){ref-type="table-fn"}   0.104         0.018[\*](#t004fn002){ref-type="table-fn"}        0.680                                        0.760                                        0.753                                          0.160
  **LPA**                                                                                                                                                                                                                                                                                                                  
  Low         70.0 (20.5)                                       39.5 (41.1)                                       53.0 (28.1)   46.8 (20.9)                                       38.1 (18.8)                                  67.7 (29.0)                                  55.3 (43.9)                                    67.1 (20.9)
  Mid-low     73.4 (18.5)                                       51.8 (42.3)                                       56.3 (29.6)   52.0 (22.0)                                       41.6 (20.3)                                  67.3 (28.6)                                  64.5 (42.1)                                    69.1 (20.6)
  Mid-high    76.9 (15.8)                                       44.3 (40.8)                                       51.1 (26.7)   52.4 (21.8)                                       41.0 (20.5)                                  67.3 (29.0)                                  63.5 (42.0)                                    66.7 (20.4)
  High        79.5 (15.6)                                       54.4 (42.0)                                       54.9 (28.3)   57.2 (21.2)                                       44.6 (20.0)                                  73.7 (26.1)                                  72.9 (39.6)                                    71.0 (17.6)
  p-value     \< 0.001[\*\*](#t004fn002){ref-type="table-fn"}   0.001[\*\*](#t004fn002){ref-type="table-fn"}      0.252         \< 0.001[\*\*](#t004fn002){ref-type="table-fn"}   0.013[\*](#t004fn002){ref-type="table-fn"}   0.049[\*](#t004fn002){ref-type="table-fn"}   0.001[\*\*](#t004fn002){ref-type="table-fn"}   0.087
  **SED**                                                                                                                                                                                                                                                                                                                  
  Low         76.5 (16.5)                                       49.7 (42.4)                                       53.2 (28.9)   52.2 (22.9)                                       43.6 (19.8)                                  69.7 (28.9)                                  63.9 (43.3                                     68.0 (19.1)
  Mid-low     76.2 (17.5)                                       43.1 (41.1)                                       51.8 (27.7)   50.3 (21.4)                                       39.3 (20.7)                                  65.8 (28.1)                                  60.5 (42.3                                     64.6 (20.0)
  Mid-high    75.6 (17.6)                                       49.0 (41.7)                                       55.2 (28.0)   54.0 (20.8)                                       41.0 (20.9)                                  68.8 (27.9)                                  65.1 (42.0                                     69.8 (20.3)
  High        72.1 (19.8)                                       48.7 (42.2)                                       54.9 (28.3)   52.4 (21.8)                                       41.8 (18.6)                                  71.7 (28.1)                                  67.1 (41.6                                     71.5 (20.0)
  p-value     0.045[\*](#t004fn002){ref-type="table-fn"}        0.348                                             0.574         0.372                                             0.175                                        0.198                                        0.433                                          0.003[\*\*](#t004fn002){ref-type="table-fn"}

HRQoL = Health-related quality of life, MVPA = Moderate- to vigorous physical activity, LPA = Light physical activity, SED = Sedentary time

HRQoL scores are presented as unadjusted means (SD). Overall differences between quartile levels of MVPA, LPA, and SED respectively are presented as p-values, \*p \< 0.05. \*\*p \< 0.01

Ranges and medians for the MVPA-. LPA- and SED quartiles are as follows

MVPA Low: 0--8 min (median 4 min), Mid-low: 8--16.9 min (median 12 min), Mid-high: 17--31 min (median 24 min), High: \> 31 min (median 46 min).

LPA Low: \< 211 min (median 178 min), Mid-low: 211--259 min (median 239 min), Mid-high: 260--317 min (median 287 min), High: ≥ 318 min (median 365min).

SED Low: \< 496 min (median 455 min), Mid-low: 497--562 min (median 531 min), Mid-high: 563--618 min (median 587 min), High: \> 618 min (median 666 min).

Relationship between HRQoL and MVPA, LPA and SED {#sec017}
------------------------------------------------

In total 774 participants provided valid data on all of the covariates in addition to PA- and HRQoL variables. [Table 4](#pone.0226613.t004){ref-type="table"} shows the associations between each of the eight HRQoL dimensions and MVPA, LPA and SED expressed in quartiles of time spent in each of the PA intensities or SED adjusted for covariates. Time spent in MVPA was positively associated with the dimensions physical functioning, role physical, general health and vitality. For physical functioning, role physical and general health, we observed an increase in score with increased MVPA, where individuals in the lower quartile (median 4 min/day) had significantly lower scores than all the other quartiles in physical functioning and lower scores than the mid-high and high quartiles in role physical and general health. For vitality, there was a nonlinear relationship with MVPA, and only the mid-high quartile had a significantly higher score than the individuals in the lower quartile. Clinically meaningful estimates (B ≥ 8 points) were found for physical functioning (low vs. the other quartiles) and role physical (low vs. mid-high and high quartiles). See [Table 5](#pone.0226613.t005){ref-type="table"} for detailed information.

10.1371/journal.pone.0226613.t005

###### Associations between HRQoL dimensions (outcomes) and MVPA-, LPA- or SED (exposures).

![](pone.0226613.t005){#pone.0226613.t005g}

                    Physical functioning                                        Role physical                                          Bodily pain        General health                                            Vitality                                                    Social functioning                                        Role emotional                                            Mental health
  ----------------- ----------------------------------------------------------- ------------------------------------------------------ ------------------ --------------------------------------------------------- ----------------------------------------------------------- --------------------------------------------------------- --------------------------------------------------------- ----------------------------------------------------------
  **MVPA**                                                                                                                                                                                                                                                                                                                                                                                          
  Low (reference)                                                                                                                                                                                                                                                                                                                                                                                   
  Mid-low           7.8 (4.4, 11.2)[\*\*](#t005fn002){ref-type="table-fn"}      5.3 (-3.3, 13.8)                                       2.4 (-3.3, 8.1)    3.2 (-0.9, 7.2)                                           2.5 (-1.4, 6.4)                                             1.9 (-3.6, 7.5)                                           4.5 (-4.0, 12.9)                                          -1.9 (-5.7, 1.8)
  Mid-high          9.6 (6.1, 13.0)[\*\*](#t005fn002){ref-type="table-fn"}      9.5 (0.8, 18.1)[\*](#t005fn002){ref-type="table-fn"}   4.5 (-1.3, 10.3)   5.7 (1.6, 9.8)[\*\*](#t005fn002){ref-type="table-fn"}     4.0 (0.1, 8.0)[\*](#t005fn002){ref-type="table-fn"}         3.7 (-2.0, 9.3)                                           4.8 (-3.7, 13.4)                                          -0.7 (-4.5, 3.1)
  High              10.7 (7.2, 14.2)[\*\*](#t005fn002){ref-type="table-fn"}     9.9 (1.3, 18.6)[\*](#t005fn002){ref-type="table-fn"}   4.6 (-1.2, 10.4)   7.2 (3.1, 11.3)[\*\*](#t005fn002){ref-type="table-fn"}    3.7 (-0.3, 7.7)                                             1.2 (-4.4, 6.9)                                           1.1 (-7.4, 9.6)                                           -0.9 (-4.7, 2.9)
  **LPA**                                                                                                                                                                                                                                                                                                                                                                                           
  Low (reference)                                                                                                                                                                                                                                                                                                                                                                                   
  Mid-low           2.4 (-1.1, 5.8)                                             10.9 (2.4, 19.4)\*                                     3.8 (-1.8, 9.5)    4.8 (0.8, 8.8)[\*](#t005fn002){ref-type="table-fn"}       5.2 (1.4, 9.0)[\*\*](#t005fn002){ref-type="table-fn"}       0.5 (-5.0, 6.0)                                           7.9 (-0.4, 16.2)                                          2.2 (-1.5, 5.9)
  Mid-high          4.7 (1.0, 8.3)[\*](#t005fn002){ref-type="table-fn"}         2.1 (-6.7, 11.0)                                       -1.1 (-7.0, 4.8)   5.2 (0.9, 9.4)[\*](#t005fn002){ref-type="table-fn"}       6.0 (2.0, 10.0)[\*\*](#t005fn002){ref-type="table-fn"}      0.5 (-5.3, 6.2)                                           7.2 (-1.5, 15.9)                                          -0.5 (-4.4, 3.4)
  High              5.3 (1.5, 9.1)[\*\*](#t005fn002){ref-type="table-fn"}       9.5 (0.2, 18.8)\*                                      0.9 (-5.3, 7.1)    7.8 (3.4, 12.3)[\*\*](#t005fn002){ref-type="table-fn"}    9.5 (5.3, 13.8)[\*\*](#t005fn002){ref-type="table-fn"}      5.7 (-0.4, 11.8)                                          14.4 (5.2, 23.5)[\*\*](#t005fn002){ref-type="table-fn"}   3.3 (-0.8, 7.3)
  **SED**                                                                                                                                                                                                                                                                                                                                                                                           
  Low (reference)                                                                                                                                                                                                                                                                                                                                                                                   
  Mid-low           -0.5 (-4.0, 2.9)                                            -5.9 (-14.4, 2.6)                                      -0.2 (-5.9, 5.5)   -1.2 (-5.3, 2.8)                                          -4.6 (-8.4,-0.7)[\*](#t005fn002){ref-type="table-fn"}       -6.1 (-11.6, -0.6)[\*](#t005fn002){ref-type="table-fn"}   -6.3 (-14.6, 2.1)                                         -5.2 (-8.9, -1.5)[\*\*](#t005fn002){ref-type="table-fn"}
  Mid-high          -2.1 (-5.6, 1.5)                                            -2.3 (-11.0, 6.4)                                      1.5 (-4.2, 7.3)    -1.3 (-5.4, 2.8)                                          -6.0 (-9.9, -2.0)[\*\*](#t005fn002){ref-type="table-fn"}    -6.3 (-11.9, -0.7)[\*](#t005fn002){ref-type="table-fn"}   -7.0 (-15.5, 1.5)                                         -2.3 (-6.1, 1.5)
  High              -7.3 (-11.3, -3.4)[\*\*](#t005fn002){ref-type="table-fn"}   -6.8 (-16.4, 2.8)                                      -1.3 (-7.7, 5.1)   -5.6 (-10.2, -1.0)[\*](#t005fn002){ref-type="table-fn"}   -8.1 (-12.5, -3.8)[\*\*](#t005fn002){ref-type="table-fn"}   -7.1 (-13.4, -0.9)[\*](#t005fn002){ref-type="table-fn"}   -7.2 (-16.6, 2.3)                                         -2.8 (-7.0, 1.4)

HRQoL = Health-related quality of life, MVPA = Moderate- to vigorous physical activity, LPA = Light physical activity, SED = Sedentary time

Associations between outcomes and exposures were controlled for gender, age, BMI, accelerometer wear time, educational level, chronic conditions, smoking status and marital status, presented as main effect estimates (B coefficients (95% CI)). Significant associations at \*p \< 0.05, \*\*p \< 0.01

Time spent in LPA was positively associated with the dimensions physical functioning, role physical, general health, vitality and role emotional, with a linear relationship between LPA and all of the dimensions except for role physical. Individuals in the lower quartile (median 2.9 hours LPA/day) had significantly lower scores in the general health and vitality dimensions than those in the three other quartiles. For physical functioning, there was a significant difference in score between the lower quartile and the mid-high and high LPA quartiles. However, for role physical, there was a nonlinear relationship, and for role emotional only individuals in the upper quartile had a significantly higher score than those in the lower quartile. Clinically meaningful estimates (B ≥ 8 points), were found for role physical (low vs. mid-low and high quartiles), general health (low vs. high quartile), vitality (low vs. high quartile) and role emotional (low vs. high quartile). For detailed information, see [Table 5](#pone.0226613.t005){ref-type="table"}.

Time spent SED was negatively associated with physical functioning, general health, vitality, social functioning and mental health ([Table 5](#pone.0226613.t005){ref-type="table"}). For vitality and social functioning there was a linear relationship with decreased scores with increasing time spent SED, and all other quartiles had significantly lower scores than the low reference quartile (median 7.6 hours). For physical functioning and general health, only the higher quartile (median 11 hours SED/day) had significantly lower scores than the low reference quartile. For mental health, there was a nonlinear relationship, in which only individuals in the mid-low group (median 8.8 hours SED/day) had significantly lower scores than the low reference quartile. Clinically meaningful estimates (B ≥ 8 points), were found for vitality (low vs. high quartile).

When models for SED and LPA were mutually adjusted for MVPA in sensitivity analysis, the following associations became non-significant: between MVPA and vitality (all p \> 0.235), between LPA and physical functioning (all p \> 0.104), and between SED and physical functioning and general health (all p \> 0.057).

We observed significant interaction effects (p \< 0.05) between age and MVPA, LPA and/or SED on physical functioning, role physical and mental health ([S3 Table](#pone.0226613.s003){ref-type="supplementary-material"}). Furthermore, there were significant interactions between BMI and MVPA, LPA and/or SED on physical functioning, bodily pain and social functioning. Gender and chronic health conditions interacted with SED only on general health. See [S3 Table](#pone.0226613.s003){ref-type="supplementary-material"} for detailed information.

[Table 6](#pone.0226613.t006){ref-type="table"} shows associations for physical functioning, role physical and mental health stratified on age. The associations between MVPA and LPA and the physical dimensions were strongest in the older age groups (\> 50 years), and no significant relationships were observed in the youngest age group (18--34 years). For mental health, the associations with LPA (positive association) and SED (negative association) were strongest in the youngest age group and no significant relationships were observed in the oldest age group (65--87 years) ([Table 6](#pone.0226613.t006){ref-type="table"}).

10.1371/journal.pone.0226613.t006

###### Associations between physical functioning, role physical or mental health as outcomes and MVPA/LPA/SED as exposures stratified by age groups.

![](pone.0226613.t006){#pone.0226613.t006g}

                                 18--34 (n = 137)                                             35--49 (n = 216)                                         50--64 (n = 291)                                          65--87 (n = 130)
  ------------------------------ ------------------------------------------------------------ -------------------------------------------------------- --------------------------------------------------------- ----------------------------------------------------------
      **Physical functioning**                                                                                                                                                                                   
  **MVPA (ref low)**                                                                                                                                                                                             
  Mid-low                        6.6 (-3.5, 16.7)                                             2.9 (-3.8, 9.6)                                          4.5 (-1.1, 10.0)                                          17.0 (8.7, 25.4)[\*\*](#t006fn001){ref-type="table-fn"}
  Mid-high                       5.5 (-4.6, 15.7)                                             4.0 (-2.5, 10.6)                                         8.8 (3.0, 14.7)[\*\*](#t006fn001){ref-type="table-fn"}    17.9 (10.4, 25.3)[\*\*](#t006fn001){ref-type="table-fn"}
  High                           -1.4 (-11.6, 8.8)                                            9.4 (2.5, 16.2)[\*\*](#t006fn001){ref-type="table-fn"}   10.5 (5.0, 15.9)[\*\*](#t006fn001){ref-type="table-fn"}   21.0 (13.0, 29.1)[\*\*](#t006fn001){ref-type="table-fn"}
  **LPA (ref low)**                                                                                                                                                                                              
  Mid-low                        -6.0 (-12.3, 7.5)                                            -2.3 (-9.6, 5.0)                                         7.7 (1.8, 13.5)[\*\*](#t006fn001){ref-type="table-fn"}    5.3 (-2.5, 13.2)
  Mid-high                       -3.1 (-12.7, 6.4)                                            0.6 (-6.4, 7.7)                                          8.3 (2.2, 14.5)[\*\*](#t006fn001){ref-type="table-fn"}    9.8 (0.6, 18.9)[\*](#t006fn001){ref-type="table-fn"}
  High                           -2.4 (-12.3, 7.5)                                            -0.2 (-7.8, 7.5)                                         11.6 (5.4, 17.8)[\*\*](#t006fn001){ref-type="table-fn"}   7.3 (-2.9, 17.6)
      **Role physical**                                                                                                                                                                                          
  **LPA (ref low)**                                                                                                                                                                                              
  **Mid-low**                    8.7 (-10.2, 27.6)                                            -3.9 (-21.8, 14.0)                                       10.8 (-4.6, 26.2)                                         22.8 (5.9, 39.8)[\*\*](#t006fn001){ref-type="table-fn"}
  **Mid-high**                   6.8 (-13.7, 27.3)                                            -11.9 (-29.2, 5.3)                                       -1.2 (-17.4, 15.0)                                        24.0 (4.2, 43.8)[\*](#t006fn001){ref-type="table-fn"}
  **High**                       9.9 (-11.3, 31.1)                                            5.1 (-13.5, 23.8)                                        1.3 (-14.9, 17.6)                                         37.0 (14.9, 59.2)[\*\*](#t006fn001){ref-type="table-fn"}
      **Mental health**                                                                                                                                                                                          
  **LPA (ref low)**                                                                                                                                                                                              
  Mid-low                        7.0 (-2.2, 16.2)                                             3.1 (-5.7, 12.0)                                         -0.8 (-6.9, 5.2)                                          2.3 (-4.4, 8.9)
  Mid-high                       12.7 (2.7, 22.7)[\*](#t006fn001){ref-type="table-fn"}        -3.2 (-11.8, 5.3)                                        -7.3 (-13.7, -0.9)[\*](#t006fn001){ref-type="table-fn"}   1.2 (-6.5, 9.0)
  High                           16.3 (6.0, 26.7)[\*\*](#t006fn001){ref-type="table-fn"}      4.8 (-4.4, 14.0)                                         -3.0 (-9.5, 3.4)                                          -3.4 (-12.0, 5.3)
  **SED (ref low)**                                                                                                                                                                                              
  Mid-low                        -8.9 (-17.5, -0.4)[\*](#t006fn001){ref-type="table-fn"}      -6.0 (-13.6, 1.6)                                        -2.4 (-8.2, 3.4)                                          -1.9 (-11.5, 7.6)
  Mid-high                       -4.1 (-13.7, 5.6)                                            -4.0 (-11.8, 3.8)                                        0.1 (-5.8, 6.0)                                           1.7 (-7.1, 10.4)
  High                           -17.6 (-27.7, -7.5)[\*\*](#t006fn001){ref-type="table-fn"}   -7.6 (-17.4, 2.1)                                        6.9 (0.4, 13.4)[\*](#t006fn001){ref-type="table-fn"}      1.8 (-7.4, 11.1)

Associations are presented as coefficients (B) (95% CI), controlled for gender, BMI, accelerometer wear time, educational level, chronic conditions, smoking status and marital status. Significant associations at \*p \< 0.05, \*\*p \< 0.01.

Stratification by age groups were based on significant interaction effects between age and the presented PA-intensities and/or SED on these dimensions.

[Table 7](#pone.0226613.t007){ref-type="table"} presents associations for bodily pain and social functioning stratified on BMI. The associations between PA or SED and bodily pain were only sporadic. However, for social functioning we observed that the only weight category with significant associations was the obese group (BMI ≥ 30).

10.1371/journal.pone.0226613.t007

###### Associations between bodily pain and social functioning as outcomes and MVPA/LPA /SED as exposures stratified by BMI categories.

![](pone.0226613.t007){#pone.0226613.t007g}

                               BMI \< 25 (n = 104)   BMI 25--29.9 (n = 194)   BMI ≥ 30 (n = 474)
  ---------------------------- --------------------- ------------------------ -------------------------
      **Bodily pain**                                                         
  **MVPA (ref low)**                                                          
  Mid-low                      5.3 (-6.5, 27.3)      -1.3 (-13.1, 10.5)       1.2 (-1.6, 13.1)
  Mid-high                     4.5 (-12.7, 21.7)     3.3 (-8.6, 15.1)         4.1 (-3.2, 11.5)
  High                         10.4 (-13.0, 23.6)    -3.5 (-15.5, 8.5)        5.7 (-6.0, 8.4)
  **LPA (ref low)**                                                           
  Mid-low                      -9.0 (-27.0, 9.0)     2.3 (-9.3, 14.0)         6.4 (1.0, 17.5)\*
  Mid-high                     -10.0 (-26.1, 6.1)    -5.9 (-18.0, 6.2)        3.3 (-4.2, 10.9)
  High                         -11.2 (-27.9, 5.5)    -7.1 (-19.3, 5.1)        9.2 (-0.7, 13.4)
  **SED (ref low)**                                                           
  Mid-low                      9.3 (-6.5, 25.1)      6.5 (-7.6, 17.1)         -6.1 (-13.6, 1.3)
  Mid-high                     -6.8 (-22.9, 9.3)     12.5 (0.7, 24.2)\*       -3.9 (-11.3, 3.5)
  High                         11.9 (-5.0, 28.9)     4.8 (-4.4, 17.5)         -9.2 (-17.8, -0.6)\*
      **Social functioning**                                                  
  **MVPA (ref low)**                                                          
  Mid-low                      -6.1 (-23.5, 11.3)    -2.4 (-20.0, 6.1)        4.4 (-2.3, 11.1)
  Mid-high                     -5.4 (-21.8, 11.0)    0.8 (-12.1, 13.7)        6.7 (-0.2, 13.6)
  High                         -6.1 (-25.8, 6.4)     -6.9 (-15.3, 10.4)       7.0 (0.2, 13.9)\*
  **LPA (ref low)**                                                           
  Mid-low                      -3.8 (-21.1, 13.5)    -3.3 (-16.0, 9.5)        1.6 (-5.0, 8.2)
  Mid-high                     -3.7 (-19.1, 11.8)    -4.5 (-17.8, 8.7)        2.7 (-4.3, 9.8)
  High                         -2.7 (-18.8, 13.4)    2.9 (-10.4, 16.2)        9.6 (1.9, 17.3)\*
  **SED (ref low)**                                                           
  Mid-low                      -4.6 (-19.9, 10.6)    -2.8 (-14.9, 9.2)        -8.7 (-15.6, -1.7)\*
  Mid-high                     -12.9 (-28.5, 2.6)    1.5 (-11.4, 14.3)        -10.0 (-16.9, -3.1)\*\*
  High                         -1.3 (-17.7, 15.1)    -1.9 (-15.5, 11.7)       -11.7 (-19.7, -3.7)\*\*

Associations are presented as coefficients (B) (95% CI), controlled for gender, age, accelerometer wear time, educational level, chronic conditions, smoking status and marital status. Significant associations at \*p \< 0.05, \*\*p \< 0.01. Stratification by BMI categories were based on significant interaction effects between BMI and MVPA, LPA and SED for these dimensions.

Discussion {#sec018}
==========

The main results from this study show that the individuals recruited to Norwegian HLCs had a low physical activity level and reported significantly lower HRQoL in all dimensions compared to data from the general Norwegian population. A positive relationship between HRQoL and both moderate to vigorous- (MVPA) and light physical activity (LPA), and a negative relationship with time spent sedentary (SED) was observed. The different PA intensities (MVPA and LPA) and SED were clinically meaningful associated (B coefficients ≥ 8) with different dimensions of HRQoL. MVPA was related to physical functioning and role physical, LPA to role physical, general health, vitality and role emotional, while SED was related to vitality. However, the associations for some of the dimensions were dependent on age and BMI category.

The Norwegian HLCs target high-risk individuals with low PA level \[[@pone.0226613.ref027]\]. Previous studies of Norwegian HLC's have found that the HLCs recruited individuals with high PA level compared to the general Norwegian population \[[@pone.0226613.ref029], [@pone.0226613.ref031]\]. Contradictory to these findings, the present study suggest that the HLCs reach physically inactive individuals. Furthermore, the vast majority were obese, had low level of education, were on sick leave or social benefits and had a high degree of multimorbidity. Our results indicating that the HLCs reach a high-risk group is essential, as previous studies have found that behavior change counseling within primary care is effective in improving health and increasing PA level when reaching high-risk individuals \[[@pone.0226613.ref048], [@pone.0226613.ref049]\], contradictory to conflicting results when targeting a healthy population without any risk factors \[[@pone.0226613.ref050]\]. The conflicting results in terms of HLC participants' PA level could possibly be attributed to smaller samples in the previous studies, or that they used self-reported PA \[[@pone.0226613.ref031]\], a different accelerometer device, or different data processing methods to classify the participants' PA levels \[[@pone.0226613.ref029]\]. PA level and SED in the current study was measured with the same device, and by using the same data processing criteria, as the Norwegian surveillance system for PA \[[@pone.0226613.ref024]\]. Adults in the present study accumulated on average 24 min of MPA per day compared to 38 and 36 min (men and women, respectively) in the general Norwegian population \[[@pone.0226613.ref024]\]. Older adults in the Norwegian population accumulated 33 min (male) and 30 min (female) of MPA, while the elderly HLC participants engaged in 16 min of MPA daily \[[@pone.0226613.ref024]\]. Only 20% of adults and 14% of older adults in the HLC sample met current PA recommendations, compared to 33% in the general adult population and 31% among older adults in Norway \[[@pone.0226613.ref024]\]. However, our findings are in line with results for obese individuals in the general population, where 16% met the PA guidelines \[[@pone.0226613.ref024], [@pone.0226613.ref051]\].

The HRQoL scores in the present study population ranged from 40 in the dimension vitality (women) to 76 in physical functioning (men). We observed substantially lower scores in all dimensions compared to the general population, ranging from 26 and 28 points lower in the role physical dimension (women and men, respectively) to 11 and 13 points lower in the mental health dimension (men and women, respectively) \[[@pone.0226613.ref033]\]. Previous studies have considered an 8-point difference in SF-36 scores as clinically important \[[@pone.0226613.ref046]\], which is comparable to the estimate of 0.5 SD \[[@pone.0226613.ref052]\]. Thus, the high-risk population in our study reported substantially, and clinically meaningful lower scores than the general Norwegian population across all dimensions \[[@pone.0226613.ref033]\]. These results confirm previous findings of lower HRQoL among individuals with chronic conditions compared to generally healthy populations \[[@pone.0226613.ref053], [@pone.0226613.ref054]\].

Furthermore, we found that HRQoL scores varied between groups with different PA- or SED levels. Existing evidence about the relationship between PA and HRQoL in adults and the elderly is mainly based on self-reported PA data \[[@pone.0226613.ref007], [@pone.0226613.ref009]\], which has limitations concerning measuring the duration of activities of certain intensities or sedentary time precisely. The use of accelerometers enabled us to classify individuals' PA and SED levels more precisely than self-reported data does, and hence, investigate the dose-response relationship between HRQoL and the various PA intensity levels. After adjustment for confounders, we observed a positive gradient of HRQoL scores in the dimensions physical functioning, role physical and general health across levels of MVPA. These results are in line with previous findings in cross-sectional studies \[[@pone.0226613.ref055], [@pone.0226613.ref056]\]. However, in the present study, the differences in scores between the two highest levels of MVPA was minor (only about one point). Our findings support previous studies suggesting there might be a threshold at which excessive MVPA do not have any further positive relationship with HRQoL \[[@pone.0226613.ref018], [@pone.0226613.ref057], [@pone.0226613.ref058]\]. Furthermore, we found that the level of MVPA needed to score clinically meaningful higher than the individuals in the lower quartile did, differed between the various dimensions. For physical functioning this level was median 12 min MVPA per day, while for role physical this level was 24 min MVPA per day. For general health, the differences in scores between levels of MVPA were less than 8 points, and hence not considered as clinical relevant.

For LPA, only individuals in the higher quartile, spending a median of 6 hours LPA per day, reported clinically meaningful higher scores than the lower quartile in the dimensions general health, vitality and role emotional. For the dimension role physical there was a non-linear trend where both the mid-low (median 4 hours LPA per day) and the higher quartile reported higher scores compared to the lower quartile. Vitality was the only dimension where there was observed a clinically relevant difference between levels of SED, in which individuals spending a median 11 hours SED per day had lower scores compared to the least sedentary individuals (median 8 hours SED per day). These findings are in line with previous studies indicating that PA at different intensities and SED are associated with different dimensions of HRQoL \[[@pone.0226613.ref017], [@pone.0226613.ref020]\], and furthermore that the dose-response relationship might differ between dimensions.

Most previous studies have investigated the relationship between HRQoL and PA of only moderate-to vigorous intensity \[[@pone.0226613.ref007], [@pone.0226613.ref009]\]. Our study confirms previous consistent findings of positive associations between MVPA and the physical-related dimensions (physical functioning and role physical) \[[@pone.0226613.ref007], [@pone.0226613.ref009]\]. However, we found that MVPA was not associated with any of the mental-related dimensions (role emotional, mental health, social functioning, or vitality) \[[@pone.0226613.ref034]\], in which previous evidence seems to be contradictory \[[@pone.0226613.ref007], [@pone.0226613.ref009], [@pone.0226613.ref018]\]. On the other hand, we found that LPA was associated with mental-related dimensions (vitality and role emotional) \[[@pone.0226613.ref034]\]. The conflicting results regarding MVPA's association to mental-related dimensions might partly be attributed to the variety of thresholds at which PA is defined as moderate- to vigorous, based on the wide specter of measurement instruments used \[[@pone.0226613.ref007], [@pone.0226613.ref009]\]. Questionnaires are prone to recall bias, and especially duration of every-day activities, which not are experienced as breath taking, may be hard to recall precisely, while one tend to over-report activity of moderate- and hard intensity \[[@pone.0226613.ref010]\]. This might have led to misclassification of LPA as MVPA in previous studies using self-reported PA. However, the current study found no associations between neither MVPA nor LPA and SED and the specific mental health dimension. Though, when we investigated the relationship stratified by age, we found statistical and clinically relevant associations between mental health and both LPA and SED for individuals in the youngest age group (18 to 34 years), indicating that the relationship possibly could be dependent on age. Furthermore, about one third of the current study's population reported mental disorders. Individuals with mental disorders have shown to score significantly lower than the general population in mental-related dimensions \[[@pone.0226613.ref054]\]. Hence, the association between mental-related dimensions and PA might have been attenuated by the individuals' chronic conditions, as we only controlled for number of chronic conditions, and not for specific disorders. Further studies are therefore needed to explore the relationship between mental health and PA in populations with multimorbidity.

The current study found no significant associations between any of the PA intensities and bodily pain or social functioning, which is in line with previous findings in the reviews by Pucci et al. \[[@pone.0226613.ref009]\] and Bize et al. \[[@pone.0226613.ref007]\]. However, we found that BMI had an interaction effect with PA and SED on bodily pain and social functioning, which might indicate that these dimensions are influenced by moderating factors such as BMI. As the current study is based on cross-sectional data, we are limited in interpreting any causality. Thus, it possible that higher BMI has an impact on bodily pain and social functioning, which in turn might influence the choice of activities, or to not engage in physical activity. Further studies with longitudinal designs are needed to investigate the causality of the relationships.

Strengths and limitations {#sec019}
-------------------------

One of the strengths of the current study is the relatively large sample of high-risk individuals from a wide range of HLCs in four regions in Norway. Thus, we believe this is a more representative sample of Norwegian HLC participants compared to the smaller samples included in previous studies \[[@pone.0226613.ref029]--[@pone.0226613.ref031]\]. Other important strengths are the adjustments for several confounders in the association analysis, the use of objective PA assessments, and a widely used, multidimensional generic HRQoL instrument, both being the same measurement methods used in previous large population surveys \[[@pone.0226613.ref024], [@pone.0226613.ref033]\]. This strengthens comparisons between populations. Although objective measurements of PA generally have higher validity than subjective assessments, there are some limitations with the use of accelerometers. First, the accelerometer is not able to capture type or characteristics of the activity performed. Setting or purpose of the activity might play an important role in terms of emotions related to the activity and hence the activity's impact on quality of life. Furthermore, cut-points used to define intensity-specific PA are not uniformly defined \[[@pone.0226613.ref039]\], which adds complexity to making comparisons across studies. The cross-sectional design of this study limits the interpretation of the causal direction of the association between PA and HRQoL, as an individual's physical or mental health could have an impact on his or her physical activity level.

In conclusion, the results from the present study showed that the majority of participants attending HLCs had low PA level and relatively low HRQoL compared to the general population. Furthermore, we found a positive relationship between PA and HRQoL and a negative relationship between SED and HRQoL. These relationships varied according to the intensity of PA and differed across dimensions of HRQoL, age, and BMI groups. Our findings might contribute to the understanding of the dose-response relationship between PA of specific intensities or SED and the various dimensions of HRQoL. However, longitudinal studies are needed to further investigate possible causal relationships.

Supporting information {#sec020}
======================

###### Linear trends between MVPA, LPA or SED and HRQoL dimensions.

Linear trends between exposures (MVPA, LPA and SED) and HRQoL dimensions (outcomes) are presented as p-values.

(PDF)

###### 

Click here for additional data file.

###### Missing item pattern.

Frequency (%) and number (n) of individuals missing items in each of the eight health-related quality of life (HRQoL) dimensions.

(PDF)

###### 

Click here for additional data file.

###### Interaction effects.

Interactions between MVPA, LPA, SED and possible moderators on HRQoL dimensions.

(PDF)

###### 

Click here for additional data file.

###### Source dataset.

(SAV)

###### 

Click here for additional data file.
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